Lewis Haut is a Nephrology physician. OpenAlex indexes 5 publications with 688 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2039 Forest Ave
Ste 301
San Jose, CA 95128
Telephone
408-998-8800Registry record last updated 8 Jul 2007.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20253 payments
- ANI Pharmaceuticals, Inc.Program year20251 payment
- Radius Health, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
44.1%Statin13.3%Atorvastatin Calcium69%Rosuvastatin Calcium18%Pravastatin Sodium6%Simvastatin6%Part D<11 patientsCalcium channel blocker8%Amlodipine Besylate78%Diltiazem 24hr Er (Cd)11%Nifedipine Er11%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
16.7%Proton pump inhibitor5.2%Pantoprazole Sodium60%Omeprazole40%Part D≥38 patientsCorticosteroid2.8%Prednisone100%Part D≥43 patients+ 9 more classes in this area
Nervous system
10.8%Benzodiazepine2.6%Alprazolam47%Lorazepam29%Diazepam13%Clonazepam11%Part D<11 patientsSSRI1.5%Trazodone Hcl58%Escitalopram Oxalate42%Part D≥12 patients+ 8 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Fanconi's Syndrome and Distal Renal Tubular Acidosis After Glue Sniffing
Annals of Internal Medicine
1980 - Protective Effect of Phosphate Restriction on Renal Function
Advances in experimental medicine and biology
1980 - Preservation of Function in Experimental Renal Disease by Dietary Restriction of Phosphate
New England Journal of Medicine
1978
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”